
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
AnHorn Medicines is a novel drug discovery company with a strong pipeline, offering therapies that target and degrade disease-related proteins. Our mission is to develop new class of drugs BIGPRO (Bi-functional liGand induced PROteolysis) under the foundation of Targeted Protein Degradation (TPD), to address a broad range of life-threatening and life-impairing diseases. We focus on novel therapies for cancer, neurodegeneration, and aging diseases. We are turning innovation into new therapeutics new opportunities to target difficult-to-treat diseases and diseases plagued by drug resistance
Drug discovery,new class medicine,drug research,targeted protein degradation,and protac
Anhorn medicines operates in the Biotechnology research industry.
Anhorn medicines's revenue is 11m - 100m
Anhorn medicines has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.